MOMO syndrome
MOMO syndrome is a rare genetic disorder characterized by four primary features: Macrosomia, Obesity, Macrocephaly, and Ocular abnormalities. The syndrome was first described in the medical literature in 1993 by Dr. C. Le Merrer and colleagues. The name MOMO is an acronym derived from the main symptoms of the disorder.
Symptoms and Characteristics[edit | edit source]
Individuals with MOMO syndrome typically present with the following features:
- Macrosomia: This refers to an abnormally large body size and is often noticeable at birth.
- Obesity: Excessive body fat accumulation, which can develop in early childhood.
- Macrocephaly: An unusually large head circumference.
- Ocular abnormalities: These can include a range of eye-related issues, such as strabismus, myopia, and other visual impairments.
Additional features may include developmental delays, intellectual disabilities, and distinctive facial features such as a prominent forehead and a broad nasal bridge.
Genetics[edit | edit source]
MOMO syndrome is believed to follow an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in MOMO syndrome have not yet been identified.
Diagnosis[edit | edit source]
Diagnosis of MOMO syndrome is primarily based on clinical evaluation and the presence of characteristic symptoms. Genetic testing may be used to support the diagnosis, although the exact genetic cause remains unknown.
Management and Treatment[edit | edit source]
There is no cure for MOMO syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary approach, including:
- Pediatricians for overall health monitoring.
- Endocrinologists for managing obesity and related metabolic issues.
- Ophthalmologists for addressing ocular abnormalities.
- Developmental pediatricians and therapists for developmental support and interventions.
Epidemiology[edit | edit source]
MOMO syndrome is extremely rare, with only a few cases reported in the medical literature. Due to its rarity, the exact prevalence is unknown.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD